申请人:NEKTAR THERAPEUTICS
公开号:US20140288315A1
公开(公告)日:2014-09-25
The invention relates to (among other things) oligomer-containing pyrrolidine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.